Anyzeila Diaz

Universidad Anahuac Oaxaca — Mexico

Medicine · Health Sciences

6h-index235citations17works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epilepsy research and treatment(11), Pharmacological Effects and Toxicity Studies(10), Neuroscience and Neuropharmacology Research(6), Drug Transport and Resistance Mechanisms(3), Asthma and respiratory diseases(1)

Publications17 total

Vacunas profilácticas y terapéuticas contra el VPH: avances en inmunogenómica y perspectivas para la prevención del cáncer de cuello uterino
Imperium Académico Multidisciplinary Journal·2025Open Access
Abstract 2843 Facing Fentanyl: Analyzing μ-Opioid Receptor Activation in the Presence of Fentanyl
Journal of Biological Chemistry·2025Open Access
rTAPP FOR THE SIMULTANEOUS TREATMENT OF RECURRENT BILATERAL SPIGELIAN AND INGUINAL HERNIAS
British journal of surgery·2024Open Access
Conversion to brivaracetam monotherapy for the treatment of patients with focal seizures: Two double-blind, randomized, multicenter, historical control, Phase III studies
Epilepsy Research·2018· 22 cited
Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis
Epilepsy & Behavior·2018· 18 citedOpen Access
A review of the pharmacology and clinical efficacy of brivaracetam
Clinical Pharmacology Advances and Applications·2018· 98 citedOpen Access
Letter re: Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
Neurology·2017
Erratum to “Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study” [Epilepsy Res. 131 (2017) 70–75]
Epilepsy Research·2017
Efficacy of adjunctive brivaracetam in patients with secondarily generalized tonic-clonic seizures at baseline: pooled results from long-term follow-up studies (P6.238)
Neurology·2017
Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study
Epilepsy Research·2017· 32 citedOpen Access
Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies
Epilepsy Research·2016· 27 citedOpen Access
Efficacy and Safety of Adjunctive Brivaracetam (BRV) for Partial-Onset (Focal) Seizures (POS) in Patients with Type IC Seizures at Baseline: Pooled Results from Three Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies (P2.042)
Neurology·2016· 3 cited
Efficacy of Brivaracetam (BRV) as Adjunctive Therapy in Partial-Onset (Focal) Seizures Among Patients with Prior Levetiracetam (LEV), Carbamazepine (CBZ), Lamotrigine (LTG), or Topiramate (TPM) Exposure (P2.027)
Neurology·2016· 3 cited
The use of newer antiepileptic drugs in patients with renal failure
Expert Review of Neurotherapeutics·2011· 23 cited
Omalizumab: A Steroid-sparing Option for Improving Pediatric Asthma Management?
Journal of Pediatric Health Care·2005· 5 cited
The clinical application of a fetal membrane on a diabetic patient's injury.
PubMed·1999· 4 cited
Pharmacokinetics of plasmatic plasminogen activator in rabbits.
PubMed·1988

Frequent Co-authors

John Whitesides(9), Pavel Klein(6), Sami Elmoufti(6), Jimmy Schiemann(6), Michael R. Sperling(4), Ali A. Asadi‐Pooya(3), Steve Chung(3), Brian D. Moseley(3), Selim R. Benbadis(3), Teresa Gasalla(2), Sami Elmouft(1), Beverly Deliz(1), Stephan Arnold(1), Vincent Badalamenti(1), Cindy McShea(1), Toufic Fakhoury(1), Leslie Briars(1), M L Reyes Frías(1), M E Martínez Pardo(1), D Luna Zaragoza(1)